These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 18512102

  • 1. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
    Moore Dalal K, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG.
    Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
    [Abstract] [Full Text] [Related]

  • 2. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
    Dalal KM, Patel A, Brady MS, Jaques DP, Coit DG.
    Ann Surg Oncol; 2007 Jun; 14(6):1934-42. PubMed ID: 17406951
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M, Jager PL, Suurmeijer AJ, Plukker JT, van Ginkel RJ, Hoekstra HJ.
    Ned Tijdschr Geneeskd; 2005 Aug 13; 149(33):1845-51. PubMed ID: 16128183
    [Abstract] [Full Text] [Related]

  • 5. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V, Breuninger H, Garbe C, Moehrle M.
    Br J Dermatol; 2006 Feb 13; 154(2):310-8. PubMed ID: 16433802
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM.
    Arch Dermatol; 2005 Aug 13; 141(8):1016-22. PubMed ID: 16103331
    [Abstract] [Full Text] [Related]

  • 8. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
    Gutzmer R, Al Ghazal M, Geerlings H, Kapp A.
    Br J Dermatol; 2005 Dec 13; 153(6):1137-41. PubMed ID: 16307648
    [Abstract] [Full Text] [Related]

  • 9. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC.
    Cancer; 1999 Dec 01; 86(11):2252-8. PubMed ID: 10590365
    [Abstract] [Full Text] [Related]

  • 10. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.
    Ann Surg Oncol; 2007 Dec 01; 14(12):3566-74. PubMed ID: 17924169
    [Abstract] [Full Text] [Related]

  • 11. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.
    Br J Dermatol; 2008 Sep 01; 159(3):597-605. PubMed ID: 18616789
    [Abstract] [Full Text] [Related]

  • 12. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
    Moran DE, Smith MJ, O'Sullivan MJ, Bannon H, Crotty TB, Collins CD, Skehan SJ, O'Higgins N, McDermott EW, Evoy D, Hill AD.
    Ir Med J; 2007 Apr 01; 100(4):422-4. PubMed ID: 17566474
    [Abstract] [Full Text] [Related]

  • 13. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
    Baker JJ, Meyers MO, Frank J, Amos KD, Stitzenberg KB, Ollila DW.
    Am J Surg; 2014 Apr 01; 207(4):549-54. PubMed ID: 24674829
    [Abstract] [Full Text] [Related]

  • 14. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
    Ranieri JM, Wagner JD, Wenck S, Johnson CS, Coleman JJ.
    Ann Surg Oncol; 2006 Jul 01; 13(7):927-32. PubMed ID: 16788753
    [Abstract] [Full Text] [Related]

  • 15. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines.
    Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF.
    Ann Surg Oncol; 2007 Jun 01; 14(6):1924-33. PubMed ID: 17357855
    [Abstract] [Full Text] [Related]

  • 16. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
    Guggenheim MM, Hug U, Jung FJ, Rousson V, Aust MC, Calcagni M, Künzi W, Giovanoli P.
    Ann Surg; 2008 Apr 01; 247(4):687-93. PubMed ID: 18362633
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
    Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG, Rees R, Wong SL, Cimmino VM, Chang AE.
    Surgery; 2007 Jun 01; 141(6):728-35. PubMed ID: 17560249
    [Abstract] [Full Text] [Related]

  • 19. Melanoma recurrence patterns after negative sentinel lymphadenectomy.
    Zogakis TG, Essner R, Wang HJ, Turner RR, Takasumi YT, Gaffney RL, Lee JH, Morton DL.
    Arch Surg; 2005 Sep 01; 140(9):865-71; discussion 871-2. PubMed ID: 16172295
    [Abstract] [Full Text] [Related]

  • 20. Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity.
    Leong WL, Ghazarian DM, McCready DR.
    J Surg Oncol; 2003 Mar 01; 82(3):143-6. PubMed ID: 12619055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.